Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 200 of 223 entries
View as:

Bioequivalence Study of Ibuprofen 200 mg Gel Capsules of Dr. Reddy's Laboratories Under Fasting Condition

Phase: N/A Priority: Normal
NCT ID: NCT01149941 Org: User:
Start: 11/30/02 End: 11/30/02 Due: 11/30/03

Bioequivalence Study of Simvastatin Tablets, 80 mg of Dr. Reddy's Under Fed Conditions

Phase: N/A Priority: Normal
NCT ID: NCT01167933 Org: User:
Start: 01/31/05 End: 04/30/05 Due: 04/30/06

Bioequivalence Study of Dr.Reddy's Laboratories Limited Finasteride Tablets 1 mg Under Fed Condition

Phase: N/A Priority: Normal
NCT ID: NCT01133457 Org: User:
Start: 04/30/02 End: 05/31/02 Due: 05/31/03

Bioequivalence Study for Donepezil Hydrochloride Tablets 10 mg Under Fed Condition

Phase: N/A Priority: Normal
NCT ID: NCT01504516 Org: User:
Start: 10/31/09 End: 12/31/09 Due: 12/31/10

Bioequivalence Study of Sumatriptan Succinate Tablets 100 mg in Fed Conditions

Phase: N/A Priority: Normal
NCT ID: NCT01269281 Org: User:
Start: 07/31/05 End: 07/31/05 Due: 07/31/06

Bioavailability Study of Ciprofloxacin 1000 mg ER Tablets of Dr. Reddy's Under Fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT01372345 Org: User:
Start: 02/28/05 End: 03/31/05 Due: 03/31/06

Clinical Trial Evaluating the Efficacy and Safety of Favipiravir in Moderate to Severe COVID-19 Patients

Phase: N/A Priority: Normal
NCT ID: NCT04529499 Org: User:
Start: 08/22/20 End: 01/27/21 Due: 01/27/22

Bio-equivalency Study of Moxifloxacin Tablets, 400 mg Under Fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT02322619 Org: User:
Start: 11/30/12 End: 12/31/12 Due: 12/31/13

A Study of the Safety and Efficacy of DFD-03 Lotion in the Treatment of Acne Vulgaris for 12 Weeks

Phase: N/A Priority: Normal
NCT ID: NCT03292640 Org: User:
Start: 07/06/17 End: 05/14/18 Due: 05/14/19

Dermal Safety Study to Evaluate the Sensitizing Potential of Abametapir Lotion

Phase: N/A Priority: Normal
NCT ID: NCT02062073 Org: User:
Start: 01/31/14 End: 06/30/14 Due: 06/30/15

Bioequivalence Study of Citalopram Hydrobromide Tablets 40 mg of Dr.Reddy's Laboratories Limited Under Fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT01149967 Org: User:
Start: 10/31/03 End: 11/30/03 Due: 11/30/04

Bioequivalence Study of Levocetirizine DiHCl Tablets 5mg of Dr. Reddy's Under Fed Conditions

Phase: N/A Priority: Normal
NCT ID: NCT01506063 Org: User:
Start: 01/31/08 End: 01/31/08 Due: 01/31/09

Bioequivalence Study of Desloratadine and Pseudoephedrine Sulfate Extended-release Tablets Under Fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT01373138 Org: User:
Start: 04/30/06 End: 05/31/06 Due: 05/31/07

Bioequivalence Study of Montelukast Sodium Tablets 10mg Under Fasting Condition

Phase: N/A Priority: Normal
NCT ID: NCT01671709 Org: User:
Start: 02/28/10 End: 03/31/10 Due: 03/31/11

Bioequivalence Study of Dr. Reddy's Divalproex Sodium Capsules (Sprinkle), 125 mg Under Fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT01055938 Org: User:
Start: 12/31/06 End: 03/31/07 Due: 03/31/08

Bioequivalence Study of Dr. Reddy's Laboratories Limited, Finasteride Tablets 1 mg Under Fasting Condition

Phase: N/A Priority: Normal
NCT ID: NCT01133444 Org: User:
Start: 04/30/02 End: 05/31/02 Due: 05/31/03

Phase IV Panitumumab Study in Indian Subjects With Metastatic Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02301962 Org: User:
Start: 07/28/15 End: 01/31/22 Due: 01/31/23

A Bioavailability Study of DFD-03 Compared to Tazorac® in Patients With Moderate Acne Vulgaris

Phase: N/A Priority: Normal
NCT ID: NCT03599193 Org: User:
Start: 10/04/17 End: 04/30/18 Due: 04/30/19

Bioequivalency Study of Divalproex Sodium DR Tablets, 500 mg of Dr.Reddy's Under Fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT01132170 Org: User:
Start: 08/31/06 End: 11/30/06 Due: 11/30/07

Bioequivalency Study of Ranitidine Tablets 300 mg of Dr. Reddy's Under Fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT01131702 Org: User:
Start: 01/31/03 End: 03/31/03 Due: 03/31/04

Bioavailability Study of Isotretinoin Capsules 40 mg Under Fed Condition

Phase: N/A Priority: Normal
NCT ID: NCT01888224 Org: User:
Start: 06/30/11 End: 07/31/11 Due: 07/31/12

Bioequivalence Study of Divalproex Sodium ER Tablets 500 mg of Dr. Reddy's Under Fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT01581775 Org: User:
Start: 01/31/11 End: 03/31/11 Due: 03/31/12

Bioequivalence Study of Mycophenolate Mofetil 250 mg Capsule, Under Fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT01513044 Org: User:
Start: 01/31/09 End: 01/31/09 Due: 01/31/10

Bioequivalence Study of Olanzapine Tablets, 5 mg of Dr. Reddy's Under Fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT01503398 Org: User:
Start: 08/31/11 End: 09/30/11 Due: 09/30/12

Bioequivalence Study of Lamotrigine 25 mg Chewable Tablets of Dr.Reddy's Under Fasting Condition

Phase: N/A Priority: Normal
NCT ID: NCT01131949 Org: User:
Start: 01/31/03 End: 03/31/03 Due: 03/31/04